FDA
approval
· 2025-05-22
FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Alembic Pharmaceuticals Inc.)
Summary
FDA approves Alembic Pharmaceuticals' fixed-dose combination of amlodipine and atorvastatin under an original ANDA application.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)